Company Description
3D Systems Corporation provides 3D printing and digital manufacturing solutions in the Americas, Europe, the Middle East, North Africa, the Asia Pacific, and Oceania.
The company offers 3D printers technologies, such as stereolithography (SLA), selective laser sintering, direct metal printing, multi jet printing, color jet printing, polymer extrusion, and extrusion and SLA based bioprinting that transform digital data input generated by 3D design software, computer aided design (CAD) software, or other 3D design tools into printed parts.
It also develops, blends, and markets various print materials, such as plastic, nylon, metal, composite, elastomeric, wax, polymeric dental materials, and biocompatible materials.
In addition, the company provides digital design tools, including software, scanners, and haptic devices, as well as solutions for product design, simulation, mold and die design, 3D scan-to-print, reverse engineering, production machining, metrology, and inspection and manufacturing workflows under the Geomagic brand.
Further, it offers 3D Sprint and 3DXpert, a proprietary software to prepare and optimize CAD data and manage the additive manufacturing processes FOR automated support building and placement, build platform management, print simulation, and print queue management.
Additionally, the company provides maintenance and training services; and precision healthcare solutions, such as design, planning, modeling, prototyping, manufacturing, printing, and finishing of medical and dental devices, anatomical models, and surgical guides and tools.
It primarily serves companies and small and midsize businesses in medical, dental, automotive, aerospace, durable goods, government, defense, technology, jewelry, electronic, education, consumer goods, energy, biotechnology, and other industries through direct sales force, channel partners, and appointed distributors.
The company was founded in 1986 and is headquartered in Rock Hill, South Carolina.
| Country | United States |
| Founded | 1986 |
| Industry | Computer Hardware |
| Sector | Technology |
| Employees | 1,925 |
| CEO | Jeffrey Graves |
Contact Details
Address: 333 Three D Systems Circle Rock Hill, South Carolina 29730 United States | |
| Phone | 803 326 3900 |
| Website | 3dsystems.com |
Stock Details
| Ticker Symbol | DDD |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000910638 |
| CUSIP Number | 88554D205 |
| ISIN Number | US88554D2053 |
| Employer ID | 95-4431352 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jeffrey Alan Graves Ph.D. | President, Chief Executive Officer and Director |
| Reji Puthenveetil | Executive Vice President of Industrial Solutions, Additive Solutions and Chief Commercial Officer |
| Jeffrey D. Creech | Executive Vice President, Principal Accounting Officer and Chief Financial Officer |
| Phyllis B. Nordstrom | Executive Vice President, Chief People Officer and Chief Administrative Officer |
| Dr. Charles W. Hull | Co-Founder, Executive Vice President, Chief Technology Officer of Regenerative Medicine and Director Emeritus |
| Dr. Joseph Zuiker | Executive Vice President of Engineering and Operations |
| Michael McCloskey | Treasurer and Vice President of Investor Relations |
| Andrew W.B. Wright J.D. | Senior Vice President of General Counsel and Corporate Secretary |
| Harriss T. Currie | President - Regenerative Medicine |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 17, 2024 | 144 | Filing |
| Dec 12, 2024 | 8-K | Current Report |
| Nov 26, 2024 | 10-Q | Quarterly Report |
| Nov 26, 2024 | 8-K | Current Report |
| Nov 22, 2024 | 8-K | Current Report |
| Nov 13, 2024 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| Nov 13, 2024 | 8-K | Current Report |
| Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 4, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Oct 17, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |